A recent drug safety communication alerted health professionals and the public about a potential increased risk of cancer associated with the weight management medication lorcaserin. The FDA has advised clinicians to consider whether the drug’s benefits outweigh its potential risks when deciding to prescribe or continue prescribing it.
Voelker R. FDA Assesses Potential Cancer Risk Associated With Weight Loss Drug. JAMA. 2020;323(7):600. doi:10.1001/jama.2020.0834
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: